Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females
MEXISPATENT
Evaluation of the Efficacy of the Cosmetic Lotion M.P.A.F. (Mixture of Paraffin, Alcohol and Fur) MEXIS PATENT in the Treatment of Androgenetic Alopecia by Decreasing of Hair Loss and Strengthening and Thickening of Hair in Males and Females.
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Androgenetic Alopecia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2001
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2001
CompletedFirst Submitted
Initial submission to the registry
October 1, 2012
CompletedFirst Posted
Study publicly available on registry
October 5, 2012
CompletedResults Posted
Study results publicly available
February 17, 2016
CompletedFebruary 17, 2016
January 1, 2016
4 months
October 1, 2012
September 13, 2013
January 20, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change of the Amount of Hair Loss in a Pull Test
Measurement of the decrease of hair loss by pull test and pulling some hair with the fingers. Measurements estimated and reported every 15 days. The Measure reports decrease in fallen hair
baseline and 90 days
Change of the Density of the Hair on a Polarized Light Video-camera as a Measure of Efficacy.
Number of hair was assessed for each participant with a polarized light video-camera every 15 days for a total of 6 assessments
baseline and 90 days
Secondary Outcomes (1)
Change of Sebum on a Sebum-meter
baseline and 90 days
Study Arms (1)
Volunteers
EXPERIMENTAL20 volunteers both men and women with an age between 18 and 70 years suffering from Androgenetic Allopecia in several types apply on the scalp drops of the hair loss prevention lotion
Interventions
For greatest problems 20 drops on the scalp per day for 3 months. For minor problems 10 drops on the scalp three times per week for 3 months.
Eligibility Criteria
You may qualify if:
- Good state of general health
- Suffering from hair loss
- No pharmacological treatment in progress
- Promise not to change the usual daily routine
- No atopy in the anamnesis
You may not qualify if:
- Illness
- Good state of hair
- Pharmacological treatment in progress
- Denial of the continuance of the usual daily routine
- Atopy in the anamnesis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mexis Georgelead
Study Sites (1)
George Mexis
Athens, 11253, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Prof. Fulvio Marzatico
- Organization
- Bio Basic Europe
Study Officials
- STUDY CHAIR
Fulvio Marzatico, Monitor
Bio Basic EuropeResearch, Development and Dermo-Cosmetoligical Documentation
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2012
First Posted
October 5, 2012
Study Start
February 1, 2001
Primary Completion
June 1, 2001
Study Completion
June 1, 2001
Last Updated
February 17, 2016
Results First Posted
February 17, 2016
Record last verified: 2016-01